platform focuses on patient-centric design and uses AI-enabled technologies to improve engagement and clinical outcomes across multiple disease areas. In addition to standalone digital therapeutics, it also offers software-enhanced drug solutions that integrate software with traditional pharmacological treatments to enhance effectiveness. Its product pipeline spans several therapeutic areas, including psychiatry, neurology, cardiometabolic conditions, and immunology, reflecting a broad approach to treating disease through digital innovation.